134 related articles for article (PubMed ID: 33647797)
21. Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system.
Okuno T; Miura K; Sakazaki F; Nakamuro K; Ueno H
Biomed Res; 2012; 33(4):201-10. PubMed ID: 22975630
[TBL] [Abstract][Full Text] [Related]
22. A20-mediated deubiquitination of ERα in the microenvironment of CD163
Lv Q; Xie L; Cheng Y; Shi Y; Shan W; Ning C; Xie B; Yang B; Luo X; He Q; Zhu Q; Zhang Y; Zhang Z; Wang C; Chen X; Xu C
Cancer Lett; 2019 Feb; 442():137-147. PubMed ID: 30420335
[TBL] [Abstract][Full Text] [Related]
23. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.
Orimo A; Inoue S; Minowa O; Tominaga N; Tomioka Y; Sato M; Kuno J; Hiroi H; Shimizu Y; Suzuki M; Noda T; Muramatsu M
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12027-32. PubMed ID: 10518570
[TBL] [Abstract][Full Text] [Related]
24. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-responsive RING finger mRNA induction in gastrointestinal carcinoma cells following bile acid treatment.
Jung B; Vogt T; Mathieu-Daudé F; Welsh J; McClelland M; Trenkle T; Weitzel C; Kullmann F
Carcinogenesis; 1998 Nov; 19(11):1901-6. PubMed ID: 9855000
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
[TBL] [Abstract][Full Text] [Related]
27. Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
Chen Z; Yang HJ; Lin Q; Zhu MJ; Yu YY; He XY; Wan XP
Cell Commun Signal; 2020 Jun; 18(1):84. PubMed ID: 32503542
[TBL] [Abstract][Full Text] [Related]
28. A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.
Cipolletti M; Bartoloni S; Busonero C; Parente M; Leone S; Acconcia F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805656
[TBL] [Abstract][Full Text] [Related]
29. Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin.
Meng YG; Han WD; Zhao YL; Huang K; Si YL; Wu ZQ; Mu YM
Cell Res; 2007 Oct; 17(10):869-80. PubMed ID: 17893710
[TBL] [Abstract][Full Text] [Related]
30. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
31. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
[TBL] [Abstract][Full Text] [Related]
32. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
[TBL] [Abstract][Full Text] [Related]
33. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
34. Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway.
Zhu Y; Shen J; Gao L; Feng Y
Oncol Rep; 2016 Apr; 35(4):2391-7. PubMed ID: 26884084
[TBL] [Abstract][Full Text] [Related]
35. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
36. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptors and their downstream targets in cancer.
Ikeda K; Inoue S
Arch Histol Cytol; 2004 Dec; 67(5):435-42. PubMed ID: 15781984
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.
Vriend J; Reiter RJ
Mol Cell Endocrinol; 2015 Dec; 417():1-9. PubMed ID: 26363225
[TBL] [Abstract][Full Text] [Related]
39. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
